Detalhe da pesquisa
1.
Combination of retagliptin and henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, active-controlled, phase 3 trial.
Diabetes Obes Metab
; 26(7): 2774-2786, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38618970
2.
MiR-221-3p regulates the microvascular dysfunction in diabetic retinopathy by targeting TIMP3.
Pflugers Arch
; 472(11): 1607-1618, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32648125
3.
miR-15b-5p ameliorated high glucose-induced podocyte injury through repressing apoptosis, oxidative stress, and inflammatory responses by targeting Sema3A.
J Cell Physiol
; 234(11): 20869-20878, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025335
4.
C1qTNF-related protein 1 improve insulin resistance by reducing phosphorylation of serine 1101 in insulin receptor substrate 1.
Endocr J
; 64(8): 787-796, 2017 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28674284
5.
Elevated circulating levels of CTRP1, a novel adipokine, in diabetic patients.
Endocr J
; 61(9): 841-7, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24965225
6.
Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China.
Diabetes
; 73(5): 797-805, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320260
7.
Increased TRPC6 expression is associated with tubular epithelial cell proliferation and inflammation in diabetic nephropathy.
Mol Immunol
; 94: 75-81, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288897